

Research on Eli Lilly & Co. and Abbott Laboratories -- Major Drug Manufacturers Look to Cancer, China and the Heart to Fill Pat
JOHANNESBURG, SOUTH AFRICA--(Marketwire - April 7, 2011) - [ www.stockcall.com/ ] offers investors comprehensive research on the Drug Manufacturers - Major industry and has completed analytical research on Eli Lilly & Co. (
With a large number of patents that have generated huge revenues expired, expiring, or set to expire soon, companies in the Drug Manufacturers - Major industry have been looking into a variety of solutions to pad their revenues. These include product development and expanding into emerging markets. Visit [ www.stockcall.com/ ] to see how companies in this industry have grown over the past years and how they are expected to perform in the future.
[ www.stockcall.com/ ] is an online platform where investors doing their due-diligence on the Drug Manufacturers - Major industry can have easy and free access to our analyst research and opinions on Eli Lilly & Co. and Abbott Laboratories; investors and shareholders of these companies can simply register for a complimentary membership at [ https://stockcall.com/development/stockcall/page.php?name=register.html ]
On the China front, companies such as Eli Lilly & Co., have announced that they plan to introduce a number of new drugs to China over the next few years. The growing middle class in China is expected to spur healthcare developments which bode well for the industry. Back home, companies are looking for the next big wonder product that will help save lives. Eli Lilly has recently reported results from preclinical studies of molecules that deter cancer causing mutations. Investors can register for free to access the research report on Eli Lilly & Co. at [ www.stockcall.com/LLY070411.pdf ].
The heart is another major area that companies in the industry are focused on. Abbott Laboratories has recently released results which show that people who used their clamps for leaky heart valves, instead of having open heart surgery, demonstrated increased survival rates. Investors can register for free to access the research report on Abbott Laboratories at [ www.stockcall.com/ABT070411.pdf ].
Register now at [ https://stockcall.com/development/stockcall/page.php?name=register.html ] to have free access to our reports on the Drug Manufacturers - Major industry.
About StockCall.com
StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines.